
Ascendis Pharma A/S ASND
$ 234.76
0.54%
Annual report 2025
added 02-28-2026
Ascendis Pharma A/S Current Ratio 2011-2026 | ASND
Annual Current Ratio Ascendis Pharma A/S
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.889 | 0.918 | 0.85 | 1.32 | 5.39 | 6.94 | 8.5 | 8.2 | 8.88 | 13.7 | 11 | 4.13 | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.7 | 0.85 | 5.89 |
Quarterly Current Ratio Ascendis Pharma A/S
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.96 | 5.39 | 5.69 | 5.18 | 5.94 | 6.94 | 11.1 | 6.72 | 8.56 | 8.5 | 9.93 | 8.33 | 16.8 | 8.2 | 10.8 | 10.1 | 20.9 | 8.88 | - | - | - | 14.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20.9 | 1.96 | 9.16 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
1.12 | $ 2.11 | -13.17 % | $ 217 M | ||
|
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | ||
|
Axsome Therapeutics
AXSM
|
1.15 | $ 163.89 | - | $ 8.15 B | ||
|
BridgeBio Pharma
BBIO
|
0.311 | $ 64.28 | -3.31 % | $ 12.3 B | ||
|
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | ||
|
BioCardia
BCDA
|
0.651 | $ 1.37 | 5.81 % | $ 29 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | ||
|
BioLineRx Ltd.
BLRX
|
1.53 | $ 2.82 | -0.35 % | $ 908 M | ||
|
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M | ||
|
BioMarin Pharmaceutical
BMRN
|
5.04 | $ 59.8 | -3.13 % | $ 11.5 B | ||
|
Bristol-Myers Squibb Company
BMY
|
1.26 | $ 62.08 | -0.46 % | $ 126 B | ||
|
Benitec Biopharma
BNTC
|
43.4 | $ 10.93 | 0.23 % | $ 450 M | ||
|
BioNTech SE
BNTX
|
7.22 | $ 109.33 | -0.82 % | $ 27.2 B | ||
|
Black Diamond Therapeutics
BDTX
|
3.12 | $ 2.38 | -3.44 % | $ 131 M | ||
|
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | ||
|
BioXcel Therapeutics
BTAI
|
0.292 | $ 1.63 | -2.4 % | $ 4.13 M | ||
|
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | ||
|
Burford Capital Limited
BUR
|
2.14 | $ 8.65 | 2.49 % | $ 1.39 B | ||
|
Adverum Biotechnologies
ADVM
|
1.65 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - | ||
|
AIkido Pharma
AIKI
|
6.48 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | ||
|
BeyondSpring
BYSI
|
0.706 | $ 1.34 | -0.87 % | $ 54 M | ||
|
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | ||
|
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | ||
|
Cabaletta Bio
CABA
|
14.5 | $ 3.34 | 0.61 % | $ 3.9 M | ||
|
Aileron Therapeutics
ALRN
|
7.98 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 4.88 | 2.74 % | $ 10.6 B | ||
|
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | ||
|
Capricor Therapeutics
CAPR
|
1.63 | $ 27.28 | -2.32 % | $ 731 M | ||
|
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | ||
|
Catalyst Biosciences
CBIO
|
3.06 | $ 11.67 | -3.47 % | $ 768 M | ||
|
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | ||
|
C4 Therapeutics
CCCC
|
3.5 | $ 3.06 | 13.3 % | $ 254 M | ||
|
Aptose Biosciences
APTO
|
0.69 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | ||
|
Athira Pharma
ATHA
|
4.22 | - | - | $ 269 M | ||
|
Codexis
CDXS
|
1.82 | $ 0.99 | -2.04 % | $ 72.7 M | ||
|
Aridis Pharmaceuticals
ARDS
|
0.378 | - | 17.91 % | $ 11.1 M |